Theracurmin™ 2X

Theracurmin™ 2X

Helps Relieve Inflammation

120 mg

75 Vegetarian Capsules ( SKU: 9250, NPN: 80057372 )

Benefits

  • Theracurmin 2X has highest concentration of Theracurmin curcumin per capsule available
  • Smaller capsule, more concentrated potency
  • Utilizes patented, natural colloidal dispersion technology to enhance bioavailability and dramatically increase curcumin levels in the blood
  • Advanced manufacturing techniques increase free curcumin blood levels in a dose-dependent linear relationship
  • Curcumin modulates an impressive number of molecular targets – enhanced absorption allows for significantly greater potency and therapeutic effect
  • High potency formula allows for easy dosing
  • Suitable for vegetarians/vegans

Feature Summary

Curcumin’s role in the prevention of atherosclerotic plaque formation, platelet aggregation, and LDL oxidation indicates
multi-fold cardiovascular benefits, and its ability to inhibit angiogenesis and induce apoptosis in cancer cells suggests
both preventative and therapeutic benefit.1-4 Prospective clinical trial data has also shown the effectiveness of Theracurmin
for knee osteoarthritis symptom relief, and a decreased need for rescue medication.5
The limiting factor in curcumin’s efficacy has been its poor systemic bioavailability as it is poorly absorbed in the
gastrointestinal tract and rapidly metabolized.6 Advanced manufacturing techniques used to make Theracurmin have
reduced its particle size over 100-fold, and the combined use of natural emulsifiers to form a colloidal suspension
has tremendously increased curcumin’s bioavailability. This significantly increases blood levels of curcumin many
times that of other preparations, including so-called enhanced forms of curcumin. Theracurmin increases curcumin
levels in a linear and dose-dependent manner, bypassing previous limits of curcumin supplementation to achieve
unparalleled blood levels of curcumin.7,8

Medicinal Ingredients

Each Capsule Contains:
TheracurminTM Curcumin* from Turmeric (Curcuma longa) (rhizome) 120 mg
*A highly bioavailable form of curcumin – the most active curcuminoid in turmeric.

Non-Medicinal Ingredients

Vegetarian capsule (carbohydrate gum [cellulose], purified water), microcrystalline cellulose, silica, croscarmellose sodium, vegetable grade magnesium stearate (lubricant).

Allergens:

Contains no artificial colours, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, egg, fish, shellfish, animal products, salt, tree nuts, or GMOs. Suitable for vegetarians/vegans. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.

Contraindications

Drug Interactions

Caution is advised when taking with anticoagulant medications. Consult a health care practitioner prior to use if undergoing chemotherapy as curcumin has been shown to enhance the effect of some chemotherapeutic medications, as well as inhibit the effect of others. A reduction in the dose of medications used to treat diabetes may be necessary, as curcumin enhances the effect of insulin.

1. Goel, A., Aggarwal, B.B. (2010). Curcumin, the golden spice from Indian saffron, is a
chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector
for normal organs. Nutr Cancer, 62(7), 919-30.
2. Morimoto, T., Sunagawa, Y., Fujita, M., et al. (2010). Novel heart failure therapy targeting
transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ J,
74(
6), 1059-66.
3. Perry, M.C., Demeule, M., Régina, A., et al. (2010). Curcumin inhibits tumor growth
and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res, 54(8), 1192-201.
4. Wongcharoen, W., Phrommintikul, A. (2019). The protective role of curcumin in
cardiovascular diseases. Int J Cardiol, 133(2), 145-51.
5. Nakagawa, Y., Mukai, S., Yamada, S., et al. (2014). Short-term effects of highly-bioavailable
curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled
prospective study. J Orthop Sci, 19(6), 933-9.
6. Anand, P., Kunnumakkara, A.B., Newman, R.A., et al. (2007). Bioavailability of curcumin:
problems and promises. Mol Pharm, 4(6), 807-18.
7. Kanai, M., Imaizumi, A., Otsuka, Y., et al. (2012). Dose-escalation and pharmacokinetic
study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability,
in healthy human volunteers. Cancer Chemother Pharmacol, 69(1), 65-70.
8. Sasaki, H., Sunagawa, Y., Takahashi, K., et al. (2011). Innovative preparation of curcumin
for improved oral bioavailability. Biol Pharm Bull, 34(5), 660-5.